Personalized medicine is based on genomic data and principles. Main target is proper prediction of risks of the disease development, early diagnostics and selection of proper therapy, which suits to the patient.
In cardiology are nowadays most common methods genome-wide studies, SNPs detection, sequencing of selected parts of genome, monitoring of epigenetic changes (methylation) and pharmacogenomics.